<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01891279</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-09-0260</org_study_id>
    <nct_id>NCT01891279</nct_id>
  </id_info>
  <brief_title>Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?</brief_title>
  <official_title>The Use of Elemental Formula in Neonates Post Small Bowel Resection: Improved Success to Wean From Total Parenteral Nutrition?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In neonates with recent small bowel resection or congenital bowel anomalies (gastroschisis or
      omphalocele), does an elemental formula as compared to a partially hydrolyzed formula allowed
      the infant to wean off Total Parenteral Nutrition (TPN) earlier?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neonates with short bowel syndrome (SBS) due to recent small bowel resection or congenital
      bowel anomalies (gastroschisis or omphalocele) can have inability to adequately digest and
      absorb enteral feedings resulting in prolonged Parenteral Nutrition (PN) dependence for
      nutrition and growth. Prolonged PN dependence can result in Parenteral Nutrition Associated
      Liver Disease (PNALD) and intestinal failure requiring small bowel or small bowel/liver
      transplantation for survival.

      After bowel resection, the bowel has an ability to compensate for significant loss by going
      through a process called intestinal adaptation. Enteral feeding is the key factor for
      initiating and maintaining the adaptation of the intestine.

      Whole protein formulas or partially hydrolyzed formulas provide either the full protein or
      dipeptides/tripeptides respectively, and are thought to confer the best benefit in inducing
      intestinal adaptation and increasing paracrine stimulation. However, in small studies of
      adults and children with SBS,an amino acid based (elemental) formula demonstrated improved
      feeding tolerance and ability to wean off TPN. In a small study, babies fed breast milk or
      elemental formula appeared to have shorter duration of TPN.

      This is a randomized, blinded clinical trial to determine if elemental formula, Elecare® (vs.
      partially hydrolyzed formula, Pregestimil®) is better tolerated and allows a higher
      proportion of neonates with small bowel resection or congenital bowel anomalies to
      successfully wean off TPN.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tolerance of TPN use</measure>
    <time_frame>6 weeks and 8 weeks after initiation of feeding</time_frame>
    <description>At 6 wks post intervention, if they are tolerating &lt; 40 enteral Kcal/k/day, this will be considered a failure to establish adaptation with the formula; if they are tolerating 41-90 enteral Kcal/k/day, this formula will be continued for 2 weeks longer;if they are tolerating &gt;90 enteral Kcal/k/day, this will be considered a weaning success.
At 8 wks post intervention, if they are tolerating &lt;90 enteral Kcal/k/day, this will be considered a failure to establish adaptation; At 8 wks post intervention, if they are tolerating &gt;90 enteral Kcal/k/day, this will be considered a weaning success.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>from birth (admission) to discharge (up to 1 year of age)</time_frame>
    <description>number of hospital days from birth to hospital discharge, up to 1 year of age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct bilirubin levels</measure>
    <time_frame>From birth (admission) to discharge (up to 1 year of age)</time_frame>
    <description>The highest and lowest direct bilirubin levels during hospitalization and direct bilirubin level at hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood stream infections</measure>
    <time_frame>From birth (admission) to discharge (up to 1 year of age)</time_frame>
    <description>Assessment for signs of infection (e.g. CBC, CRP, blood cultures, UA, stool studies, C. diff) is routine.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Short Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>elemental formula, Elecare®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Babies will receive elemental formula, Elecare®, if breast milk is not available.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>part hydrolyzed formula, Pregestimil®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Babies will receive partially hydrolyzed formula, Pregestimil®, if breast milk is not available.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>elemental formula Elecare®</intervention_name>
    <description>Babies will be randomized to received either elemental formula (Elecare®) or partially hydrolyzed formula (Pregestimil®) if breast milk is not available.</description>
    <arm_group_label>elemental formula, Elecare®</arm_group_label>
    <other_name>Elecare®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>partially hydrolyzed formula</intervention_name>
    <description>Babies will be randomized to received either partially hydrolyzed formula (Pregestimil®) or elemental formula (Elecare®)if breast milk is not available.</description>
    <arm_group_label>part hydrolyzed formula, Pregestimil®</arm_group_label>
    <other_name>Pregestimil®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term or pre-term neonates with either surgical resection of the small bowel or
             congenital bowel anomalies (gastroschisis, omphalocele) unable to tolerate
             90kcal/kg/day of enteral feedings by 1 month of age

        Exclusion Criteria:

          -  Term or preterm neonates with NEC totalis,

          -  Inborn Errors of Metabolism, or

          -  Known or suspected congenital syndromes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>See W Chan, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>See W Chan, MD, MPH</last_name>
    <phone>713-500-5845</phone>
    <email>see.w.chan@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Memorial Hermann Hosiptal Neonatal Intensive Care Unit</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>See W Chan, MD, MPH</last_name>
      <phone>713-500-5845</phone>
      <email>see.w.chan@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amir M Khan, MD</last_name>
      <phone>713-500-5733</phone>
      <email>Amir.M.Khan@uth.tmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Amir M Khan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Essam Imseis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Vanderhoof JA. Short bowel syndrome in children and small intestinal transplantation. Pediatr Clin North Am. 1996 Apr;43(2):533-50. Review.</citation>
    <PMID>8614614</PMID>
  </reference>
  <reference>
    <citation>Vanderhoof JA. Short bowel syndrome. Clin Perinatol. 1996 Jun;23(2):377-86. Review.</citation>
    <PMID>8780910</PMID>
  </reference>
  <reference>
    <citation>Bines JE, Taylor RG, Justice F, Paris MC, Sourial M, Nagy E, Emselle S, Catto-Smith AG, Fuller PJ. Influence of diet complexity on intestinal adaptation following massive small bowel resection in a preclinical model. J Gastroenterol Hepatol. 2002 Nov;17(11):1170-9.</citation>
    <PMID>12453276</PMID>
  </reference>
  <reference>
    <citation>Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr. 1998 Feb;26(2):123-8.</citation>
    <PMID>9481624</PMID>
  </reference>
  <reference>
    <citation>Lai HS, Chen WJ, Chen KM, Lee YN. Effects of monomeric and polymeric diets on small intestine following massive resection. Taiwan Yi Xue Hui Za Zhi. 1989 Oct;88(10):982-8.</citation>
    <PMID>2634733</PMID>
  </reference>
  <reference>
    <citation>Cosnes J, Evard D, Beaugerie L, Gendre JP, Le Quintrec Y. Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition. 1992 Nov-Dec;8(6):406-11.</citation>
    <PMID>1486247</PMID>
  </reference>
  <reference>
    <citation>Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, Collier SB, Lo C, Duggan C. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001 Jul;139(1):27-33.</citation>
    <PMID>11445790</PMID>
  </reference>
  <reference>
    <citation>Rhoads JM, Plunkett E, Galanko J, Lichtman S, Taylor L, Maynor A, Weiner T, Freeman K, Guarisco JL, Wu GY. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr. 2005 Apr;146(4):542-7.</citation>
    <PMID>15812462</PMID>
  </reference>
  <reference>
    <citation>Jianfeng G, Weiming Z, Ning L, Fangnan L, Li T, Nan L, Jieshou L. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res. 2005 Aug;127(2):177-82.</citation>
    <PMID>15921697</PMID>
  </reference>
  <reference>
    <citation>Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology. 2003 May;124(5):1210-9.</citation>
    <PMID>12730862</PMID>
  </reference>
  <reference>
    <citation>Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 Dec;119(6):1496-505.</citation>
    <PMID>11113071</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2012</study_first_submitted>
  <study_first_submitted_qc>July 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2013</study_first_posted>
  <last_update_submitted>March 28, 2014</last_update_submitted>
  <last_update_submitted_qc>March 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Chan See Wai</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>short bowel syndrome</keyword>
  <keyword>Elemental formula</keyword>
  <keyword>partially hydrolyzed formula</keyword>
  <keyword>Enteral feeding</keyword>
  <keyword>TPN dependency</keyword>
  <keyword>Intestinal adaptation</keyword>
  <keyword>TPN cholestasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Short Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

